Damora Therapeutics (DMRA) EPS (Diluted) (2021 - 2026)
Damora Therapeutics (DMRA) EPS (Diluted) (2021 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Diluted) (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 4.31 |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 12.23 |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 7.33 |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | -3.06 |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 0.16 |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 0.00 |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 0.15 |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 1.19 |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | -0.06 |
| 10 | Damora Therapeutics | 1.92 Bn | 1.38 Bn | - | -0.51 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -0.51 |
| Mar 31, 2026 | -0.81 |
| Dec 31, 2025 | -144.44 |
| Sep 30, 2025 | -2.36 |
| Jun 30, 2025 | -2.60 |
| Mar 31, 2025 | -1.92 |
| Dec 31, 2024 | -5.83 |
| Sep 30, 2024 | -3.39 |
| Jun 30, 2024 | -0.20 |
| Mar 31, 2024 | -0.20 |
| Dec 31, 2023 | 0.06 |
| Sep 30, 2023 | -0.30 |
| Jun 30, 2023 | -0.41 |
| Mar 31, 2023 | -0.58 |
| Dec 31, 2022 | -0.54 |
| Sep 30, 2022 | -0.54 |
| Jun 30, 2022 | -0.68 |
| Mar 31, 2022 | -0.68 |
| Dec 31, 2021 | -0.54 |
| Sep 30, 2021 | -0.50 |